Target Name: VWF
NCBI ID: G7450
Other Name(s): VWF_HUMAN | Coagulation factor VIII VWF | vWF | Factor VIII related antigen | Von Willebrand factor preproprotein | Von Willebrand antigen 2 | von Willebrand antigen 2 | von Willebrand factor | von Willebrand antigen II | VWD | Von Willebrand antigen II | Von Willebrand factor | coagulation factor VIII VWF | F8VWF

Understanding Volkswagen Foundation Fundamentals: A Potential Drug Target

Volkswagen Foundation Fundamentals (VWF) is a protein that is found in the bloodstream of humans. It is a key factor in the immune system and plays a crucial role in fighting off infections and diseases. There is a lot of research being done on VWF, and it has the potential to be a drug target or biomarker.

VWF is a glycoprotein that is made up of four subunits. It is found in the bloodstream and is produced by the liver. It has a molecular weight of approximately 180 kDa and has five potential domains: a N-terminus, a signal domain, a variable region, a carboxyyletin terminal domain, and a C-terminus. The signal domain is the region of the protein that contains the amino acids that give it its unique structure and function.

One of the unique features of VWF is its structure. It has a very specific way of being structured, and this structure is important for its functions in the immune system. The signal domain of VWF contains a unique folds that are specific to VWF. These folds allow the protein to interact with other proteins and molecules that are important to the immune system. This interaction with other proteins is important for VWF's ability to work correctly and to help the immune system fight off infections and diseases.

Another important function of VWF is its role in the immune response. VWF is involved in the regulation of the immune response by controlling the movement of immune cells. It does this by interacting with other proteins called chemokines, which are proteins that are produced by the immune system in response to the presence of an infection or disease.

In addition to its role in the immune system, VWF has also been shown to have a number of potential drug-like properties. For example, VWF has been shown to be a good candidate for a drug that is used to treat cancer, and it has also been shown to have anti-inflammatory properties.

Overall, VWF is a protein that is important for the immune system and has a number of potential drug-like properties. As a result, it is a promising target for drug development. Further research is needed to fully understand the functions of VWF and to determine its potential as a drug.

Protein Name: Von Willebrand Factor

Functions: Important in the maintenance of hemostasis, it promotes adhesion of platelets to the sites of vascular injury by forming a molecular bridge between sub-endothelial collagen matrix and platelet-surface receptor complex GPIb-IX-V. Also acts as a chaperone for coagulation factor VIII, delivering it to the site of injury, stabilizing its heterodimeric structure and protecting it from premature clearance from plasma

More Common Targets

VXN | WAC | WAC-AS1 | WAKMAR1 | WAKMAR2 | WAPL | WARS1 | WARS2 | WARS2-AS1 | WAS | WASF1 | WASF2 | WASF3 | WASF4P | WASF5P | WASH complex | WASH2P | WASH3P | WASH4P | WASH5P | WASH6P | WASH7P | WASH8P | WASHC1 | WASHC2A | WASHC2C | WASHC3 | WASHC4 | WASHC5 | WASIR1 | WASL | WAVE1 complex | WBP1 | WBP11 | WBP11P1 | WBP1L | WBP2 | WBP2NL | WBP4 | WDCP | WDFY1 | WDFY2 | WDFY3 | WDFY3-AS2 | WDFY4 | WDHD1 | WDPCP | WDR1 | WDR11 | WDR11-DT | WDR12 | WDR13 | WDR17 | WDR18 | WDR19 | WDR20 | WDR24 | WDR25 | WDR26 | WDR27 | WDR3 | WDR31 | WDR33 | WDR35 | WDR35-DT | WDR36 | WDR37 | WDR38 | WDR4 | WDR41 | WDR43 | WDR44 | WDR45 | WDR45B | WDR46 | WDR47 | WDR48 | WDR49 | WDR5 | WDR53 | WDR54 | WDR55 | WDR59 | WDR5B | WDR6 | WDR62 | WDR64 | WDR7 | WDR70 | WDR72 | WDR73 | WDR74 | WDR75 | WDR76 | WDR77 | WDR81 | WDR82 | WDR82P1 | WDR83 | WDR83OS